PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Northumbria Pharma Limited
NP

Northumbria Pharma Limited

Sedgefield
SME

Northumbria Pharma Limited is dedicated to the research, development, manufacturing, and licensing of a wide array of pharmaceutical products, including new chemical entities and generic formulations. They focus on delivering high-quality, affordable medicines to meet patient needs.

northumbriapharma.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£729.3m
Live
5
Buyers
3
12m
£729.3m
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts5 / 8
  • Top buyers3
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Northumbria Pharma LimitedUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Northumbria Pharma Limited has won £729.3m across 3 public-sector buyers, with 5 live contracts. No active Companies House risk flags.

Why: top buyer NHS England at 100% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
ActiveCompany status
5 of 8Live contracts
100%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value

Commitments mapped to the Government Social Value Model themes.

⚑ Self-reported
—

No social-value commitments yet

Jobs, skills, environmental, inequality and community commitments appear here once a claimed supplier attributes them to awarded contracts, or once we detect them on the supplier’s website.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 3
Regulatory Service and Quality AssurancePreparation of regulatory dossiers for Marketing Authorisation Applications, conducting service or product supplier audits, and providing QP services on a contract basis. ↗Quality Control LaboratoryMaintaining high standards through compliance with GMP guidelines, conducting ICH-compliant stability studies, and using a range of analytical techniques. ↗Distribution and OutlicensingFacilitating product distribution in various countries and managing full product life cycle from development to registration. ↗

Extracted automatically from northumbriapharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships · 2

Credentials listed on the supplier’s website. Not yet checked against issuer registers.

◐ From supplier website
Core credentials · 0/6
Cyber EssentialsNot evidenced✓
Cyber Essentials PlusNot evidenced✓
ISO 27001 — Information securityNot evidenced✓
ISO 9001 — QualityNot evidenced✓
ISO 14001 — EnvironmentalNot evidenced✓
ISO 45001 — Health & safetyNot evidenced✓
Other credentials & memberships · 2
Carbon Neutral CertificationStandard ↗Carbon Offset CertificationStandard ↗

Extracted automatically from northumbriapharma.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 5 live · 3 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS England—01 Sept 2026£4.2m1.8 yrspending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England—01 Jun 2026£403.7m2 yrspending
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS England—01 Mar 2026£321.3m2 yrspending
NHS National Generic Pharmaceuticals - Wave 15c
NHS England————Live
NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products
NHS England————Live
NHS National Generics Pharmaceuticals - Supply Chain Resilience
NHS England————Live
Medicinal Products and Pharma Funded Homecare [5749446]
Northern Health and Social Care Trust NHSCT85312200———Live
NHS National Generic Pharmaceuticals Wave 13
The NHS Commissioning Board (operating under the name of NHS England)33600000———Live
Total live value — · mean award £91.2m

Top buyers · 3 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
6 contracts
100%
since 2025
2
Northern Health and Social Care Trust NHSCT
1 contract
0%
3
The NHS Commissioning Board (operating under the name of NHS England)
1 contract
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire6 contracts
100%
Northern Ireland1 contract
0%
North West1 contract
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Northumbria Pharma Limited highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
NP
Northumbria Pharma Limited
Yes£729.3m—
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m17
JA
Janssen-Cilag Ltd
Yes£117.6m16
AB
AbbVie Ltd
Yes£95.2m11
TA
Thornton and Ross Ltd
Yes£72.5m9
AC
ACCORD-UK LTD
Yes£71.2m18
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
✓ Clean. No active risk signals from Companies House status, charges or insolvency records.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
Trading status
Active
Live at Companies House
Annual accounts
Up to date
Last made up to 30 Apr 2025
Confirmation statement
Up to date
Next due 01 Sept 2026
Outstanding charges
0
No charges registered
Insolvency history
None
No insolvency cases registered
Certifications (ISO, Cyber Essentials, Living Wage, B-Corp, modern-slavery) are supplier self-reported and appear once a claimed profile adds them.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Live sync — registered details, directors, PSC and SIC codes.

✓ Live sync

Registered details

Company no.
10509764
Status
Active
Type
Private limited
Incorporated
05 Dec 2016
Reg. office
Netpark, Thomas Wright Way, Sedgefield, County Durham, TS21 3FD
SIC codes
21200
Last accounts
30 Apr 2025
Next accounts due
31 Jan 2027

Directors & PSC

  • WATSON, Paul — director
    Appointed 05 Dec 2016
  • Northumbria Pharma Group Holdings Ltd — person with significant control
    ownership of shares 75 to 100 percent · voting rights 75 to 100 percent

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
NORTHUMBRIA PHARMA LTD
10509764 · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.